Consecutive gonadotropin-releasing hormone-antagonist in vitro fertilization cycles: does the elapsed time interval between successive treatments affect outcomes?

被引:26
|
作者
Reichman, David E. [1 ]
Chung, Pak [1 ]
Meyer, Laura [1 ]
Greenwood, Eleni [2 ]
Davis, Owen [1 ]
Rosenwaks, Zev [1 ]
机构
[1] Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY USA
[2] Weill Cornell Med Ctr, New York, NY 10021 USA
关键词
IVF; consecutive cycles; time interval; OVARIAN HYPERSTIMULATION SYNDROME; GNRH ANTAGONIST; LUTEAL SUPPORT; STIMULATION; PROTOCOL; AGONIST; TRIGGER;
D O I
10.1016/j.fertnstert.2012.11.044
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To determine whether patients who failed an in vitro fertilization (IVF) cycle can proceed with a subsequent IVF cycle after waiting only one menstrual cycle, or whether there is a benefit to allowing two or more menstrual cycles to elapse before proceeding. Design: Retrospective cohort study. Setting: Academic medical center. Patient(s): All patients undergoing IVF cycles at The Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medical College, from January 1, 2002 to November 1, 2011, in whom two consecutive gonadotropin-releasing hormone (GnRH)-antagonist IVF cycles with identical stimulation protocols took place 35-140 days apart, excluding patients in whom the first cycle resulted in a clinical pregnancy. Intervention(s): None. Main Outcome Measure(s): IVF outcomes were compared for 164 patients who initiated a cycle after waiting only one menstrual cycle (35-55 days from previous oocyte retrieval) versus 557 patients waiting two or more menstrual cycles (56-140 days) from their last retrieval before proceeding with their successive cycle start, stratifying for age. Result(s): No differences were detected regarding E-2 response, oocyte yield, fertilization, or embryo development when comparing patients waiting only one cycle with those waiting two or more cycles, nor were those parameters different when comparing patients' index cycles with their immediate preceding failed cycles. Moreover, clinical outcomes regarding clinical pregnancy, live birth, and cycle cancellation were similar between both study groups. Conclusion(s): Delaying successive IVF cycle start for two or more menstrual cycles likely offers no advantage over pursuing repeated IVF after one menstrual cycle. (Fertil Steril (R) 2013; 99:1277-82. (C) 2013 by American Society for Reproductive Medicine.)
引用
收藏
页码:1277 / 1282
页数:6
相关论文
共 50 条
  • [41] A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer
    Propst, Anthony M.
    Bates, G. Wright
    Robinson, Randal D.
    Arthur, Nancy J.
    Martin, Joseph E.
    Neal, Greg S.
    FERTILITY AND STERILITY, 2006, 86 (01) : 58 - 63
  • [42] Retrospective analysis of the use of two recombinant follitropin alfa injections in patients undergoing in vitro fertilization treatment with the gonadotropin-releasing hormone antagonist protocol
    Sprem Goldstajn, Marina
    Dumancic, Stipe
    Mikus, Mislav
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2021, 47 (03) : 992 - 1001
  • [43] Luteinizing hormone concentrations after gonadotropin-releasing hormone antagonist administration do not influence pregnancy rates in in vitro fertilization-embryo transfer
    Merviel, P
    Antoine, JM
    Mathieu, E
    Millot, F
    Mandelbaum, J
    Uzan, S
    FERTILITY AND STERILITY, 2004, 82 (01) : 119 - 125
  • [44] Is the type of gonadotropin-releasing hormone suppression protocol for ovarian hyperstimulation associated with ectopic pregnancy in fresh autologous cycles for in vitro fertilization?
    Londra, Laura
    Moreau, Caroline
    Strobino, Donna
    Bhasin, Aarti
    Zhao, Yulian
    FERTILITY AND STERILITY, 2016, 106 (03) : 666 - 672
  • [45] Effect of Dual Trigger In Vitro Fertilization and Intracytoplasmic Sperm Injection During the Gonadotropin-releasing Hormone-Antagonist Cycle on Final Oocyte Maturation and Cumulative Live Birth Rate in Women with Diminished Ovarian Reserve
    Ren, Yu-meng
    Wang, Yan-bin
    Fu, Min
    Zhang, Qiu-xiang
    Shen, Huan
    Han, Hong-jing
    Gao, Fu-mei
    CURRENT MEDICAL SCIENCE, 2022, 42 (05) : 1066 - 1070
  • [46] Efficacy of the depot gonadotropin-releasing hormone agonist protocol on in vitro fertilization outcomes in young poor ovarian responders from POSEIDON group 3
    Li, Wenshu
    Zhang, Wei
    Zhao, Huishan
    Chu, Yongli
    Liu, Xuemei
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2022, 157 (03) : 733 - 740
  • [47] Vascular endothelial growth factor and inhibin A in follicular fluid of infertile patients who underwent in vitro fertilization with a gonadotropin-releasing hormone antagonist
    Cunha, JS
    Lemos, N
    Stein, N
    Laranjeira, A
    Passos, EP
    FERTILITY AND STERILITY, 2005, 83 (04) : 902 - 907
  • [48] A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization
    Morgia, F
    Sbracia, M
    Schimberni, M
    Giallonardo, A
    Piscitelli, C
    Giannini, P
    Aragona, C
    FERTILITY AND STERILITY, 2004, 81 (06) : 1542 - 1547
  • [49] Cycle day, estrogen level, and lead follicle size: analysis of 27,790 in vitro fertilization cycles to determine optimal start criteria for gonadotropin-releasing hormone antagonist
    Schumacher, Brianna M. Lyttle
    Mersereau, Jennifer E.
    Steiner, Anne Z.
    FERTILITY AND STERILITY, 2018, 109 (04) : 633 - 637
  • [50] Early Follicular Phase Human Chorionic Gonadotropin Addition May Improve the Outcomes of In Vitro Fertilization/Intracytoplasmic Sperm Injection in Patients With "Unpredictable" Poor Response to Gonadotropin-Releasing Hormone Antagonist Protocol
    Zhang, Chunhui
    Wu, Fangrong
    Wu, Zexuan
    Sun, Bolan
    Chen, Cheng
    Qian, Weiping
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12